PDS Biotechnology CorporationPDSBNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-6.78%
↑ 26% above average
Average (39q)
-9.19%
Historical baseline
Range
High:64.40%
Low:-202.45%
CAGR
+1.0%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -6.78% |
| Q2 2025 | 16.28% |
| Q1 2025 | -23.71% |
| Q4 2024 | 27.69% |
| Q3 2024 | -17.21% |
| Q2 2024 | 14.00% |
| Q1 2024 | 2.97% |
| Q4 2023 | 1.07% |
| Q3 2023 | 17.14% |
| Q2 2023 | -34.74% |
| Q1 2023 | 49.94% |
| Q4 2022 | -158.56% |
| Q3 2022 | -2.63% |
| Q2 2022 | 16.35% |
| Q1 2022 | -34.13% |
| Q4 2021 | 9.20% |
| Q3 2021 | -36.36% |
| Q2 2021 | -67.45% |
| Q1 2021 | 24.29% |
| Q4 2020 | -3.09% |
| Q3 2020 | -33.07% |
| Q2 2020 | 22.81% |
| Q1 2020 | -45.65% |
| Q4 2019 | 55.34% |
| Q3 2019 | -36.90% |
| Q2 2019 | 13.47% |
| Q1 2019 | -202.45% |
| Q4 2018 | 63.34% |
| Q3 2018 | 64.40% |
| Q2 2018 | 37.77% |
| Q1 2018 | -24.64% |
| Q4 2017 | -47.88% |
| Q3 2017 | 17.08% |
| Q2 2017 | -11.52% |
| Q1 2017 | -7.79% |
| Q4 2016 | -6.44% |
| Q3 2016 | -10.93% |
| Q2 2016 | -2.57% |
| Q1 2016 | -1.81% |
| Q4 2015 | -4.55% |